Apovlam SA
6.1 FTEApovlam reported revenue of €22.1m for the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 6.1 full-time equivalents.
The score of Apovlam shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +39 % Total assets +22 % Headcount (avg FTE) +103 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apovlam's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €22.1m | ||||
| Net result | 651,130 € | ||||
| Equity | €7.03m | ||||
| Cash | 421,281 € | ||||
| EBITDA | €1.33m | ||||
| Total assets | €11.0m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 02 Oct 2025
- Year ended 31 Dec 2023filed on 27 Aug 2024
- Year ended 31 Dec 2022filed on 26 Oct 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Apovlam's financial analysis
- Solvency63.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apovlam
Apovlam's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0458.904.030
- VAT number
- BE0458904030
- Peppol
- Registered · 0208:0458904030 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Sep 1996
- Registered office
- 8908 Ypres
- Size
- Micro · 6.1 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apovlam (SA) has been based in Ypres since 1996, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of €22.1m, a net profit of 651,130 € and equity of €7.03m. With 6.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 63.9%, above the median of its sector (44.2%).
Companies similar to Apovlam
Companies in the same business, of comparable size and area, outside its group.
- Oxycure Retail sale of pharmaceutical products Fernelmont · balance sheet €11.2m
- Pharmacie Houba Retail sale of pharmaceutical products Brussels · balance sheet €8.75m
- Inveda Retail sale of pharmaceutical products Ostend · balance sheet €13.6m
- Apotheek Dessein Retail sale of pharmaceutical products Beernem · balance sheet €9.75m
- M.D.D. Pharma Retail sale of pharmaceutical products Wavre · balance sheet €12.2m
- Apotheken Solidaris Retail sale of pharmaceutical products Hasselt · balance sheet €8.84m
- Dermatheek Retail sale of pharmaceutical products Ranst · balance sheet €5.46m
- Vooruit NR. 1 Retail sale of pharmaceutical products Ghent · balance sheet €18.3m
Frequently asked questions about Apovlam
What is the revenue of Apovlam?
According to the 2025 annual accounts filed with the NBB, the revenue of Apovlam amounts to 22,109,660 €.
What is the VAT number of Apovlam?
In Belgium, the VAT number is the company number prefixed with BE: BE0458904030 for Apovlam, if the company is VAT-registered. Its company number (CBE) is 0458.904.030.
Where is the registered office of Apovlam?
According to the CBE register, the registered office of Apovlam is in 8908 Ypres.
What is the equity of Apovlam?
At the close of the 2025 financial year, the equity of Apovlam amounts to 7,027,274 €, a solvency of 63.9% of total assets.
How many people work at Apovlam?
6.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apovlam?
The register lists 3 active mandates at Apovlam. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apovlam
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →